International Scholarly Research Notices

Table of Contents

Filter by Subject
A
B
C
D
E
F
G
H
I
M
N
O
P
R
S
T
U
V
Z
  • ISRN Inflammation -
  • Special Issue
  • Volume 2012
  • - Article ID 731472
  • - Research Article

Cytokines and Growth Factors Promote Airway Smooth Muscle Cell Proliferation

R. Stamatiou | E. Paraskeva | ... | A. Hatziefthimiou
  • ISRN Inflammation -
  • Special Issue
  • Volume 2012
  • - Article ID 481432
  • - Research Article

Implication of NADPH Oxidases in the Early Inflammation Process Generated by Cystic Fibrosis Cells

Nushjira Pongnimitprasert | Margarita Hurtado | ... | Françoise Braut-Boucher
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 817478
  • - Review Article

Overview of Achievements and Challenges of the Fight against AIDS in China

Laiyi Kang
  • ISRN Inflammation -
  • Special Issue
  • Volume 2012
  • - Article ID 267101
  • - Review Article

Modulation of Bacterial Pathogenesis by Oppressive Aging Factors: Insights into Host-Pneumococcal Interaction Strategies

Pooja Shivshankar
  • ISRN Inflammation -
  • Special Issue
  • Volume 2012
  • - Article ID 953461
  • - Review Article

Acute Phase Reactants as Novel Predictors of Cardiovascular Disease

M. S. Ahmed | A. B. Jadhav | ... | Qing H. Meng
  • ISRN Inflammation -
  • Special Issue
  • Volume 2012
  • - Article ID 260453
  • - Research Article

The Importance of Myeloperoxidase in Apocynin-Mediated NADPH Oxidase Inhibition

Ana Carolina de Almeida | Maria Marluce dos Santos Vilela | ... | Valdecir F. Ximenes
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 963879
  • - Review Article

New Aspects in Immunopathology of Mycobacterium tuberculosis

E. Mortaz | M. Varahram | ... | MR Masjedi
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 324235
  • - Clinical Study

The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

Steven E. Finkelstein | Andy Trotti | ... | Ronald DeConti
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 530179
  • - Clinical Study

Resection and Immunotherapy for Recurrent Grade III Glioma

Iris Elens | Steven De Vleeschouwer | ... | Stefaan Van Gool
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 719821
  • - Research Article

Course of Antibody Response in Lyme Borreliosis Patients before and after Therapy

Elisabeth Aberer | Gerold Schwantzer
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 609128
  • - Review Article

HIV and AIDS Programmes in Zimbabwe: Implications for the Health System

Tafadzwa Chevo | Sandra Bhatasara
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 876203
  • - Review Article

The Role of Granulysin in Cancer Immunology

Satoshi Okada | Tetsuo Morishita
  • ISRN Immunology -
  • Special Issue
  • Volume 2012
  • - Article ID 382189
  • - Clinical Study

Evaluation of the Immune Response of Individuals Infected with Mycobacterium tuberculosis and Patients with Active Tuberculosis

Tânia Mara Pinto Dabés Guimarães | Vicente de Paulo Coelho Peixoto de Toledo | ... | Silvana Spíndola de Miranda
  • ISRN Immunology -
  • Special Issue
  • Volume 2011
  • - Article ID 230130
  • - Research Article

Abscopal” Effect of Radiation Therapy Combined with Immune-Therapy Using IFN-γ Gene Transfected Syngeneic Tumor Cells, in Rats with Bilateral Implanted N29 Tumors

Bertil R. R. Persson | Catrin Bauréus Koch | ... | Leif G. Salford
  • ISRN Immunology -
  • Special Issue
  • Volume 2011
  • - Article ID 584682
  • - Research Article

Consumption of Galactooligosaccharides together with Probiotics Stimulates the In Vitro Peripheral Blood Mononuclear Cell Proliferation and IFNγ Production in Healthy Men

Reetta Holma | Riina A. Kekkonen | ... | Riitta Korpela

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.